Article Details

TD Cowen Sticks to Its Buy Rating for Ikena Oncology (IKNA) - Markets Insider

Retrieved on: 2024-05-30 00:27:25

Tags for this article:

Click the tags to see associated articles and topics

TD Cowen Sticks to Its Buy Rating for Ikena Oncology (IKNA) - Markets Insider. View article details on hiswai:

Excerpt

Ikena Oncology Inc is an oncology company. It is focused on developing novel cancer therapies targeting key signaling pathways that drive the ...

Article found on: markets.businessinsider.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up